3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
3
Head & Neck
1
Gynecologic
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Cervical Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Ovarian Neoplasms
1
Oropharyngeal Neoplasms
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Endometrial Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
pembrolizumab
29
Paclitaxel
7
Magnetic Resonance Spectroscopy
7
Cisplatin
7
Pemetrexed
6
Docetaxel
6
Carboplatin
6
Standard of Care
5
Radiotherapy
5
Nivolumab
5
Drug Therapy
5
Specimen Handling
4
Gemcitabine
4
Cetuximab
4
Blood Specimen Collection
4
epacadostat
3
X-Rays
3
Surveys and Questionnaires
3
Practice Guidelines as Topic
3
Oncolytic Virotherapy
3
Nicotine
3
Fluorouracil
3
Filgrastim
3
Cyclophosphamide
3
Bupropion
3
Bortezomib
3
Biopsy
3
spartalizumab
2
selpercatinib
2
sargramostim
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Lung Neoplasms
×
Diphenhydramine
×
Head & Neck
×
Clear all
NCT04237090
2020-10-12
PREMED-F1
Ciusss de L'Est de l'Île de Montréal
Phase 3
Completed
27 enrolled